|
201 |
Invitation of Applications under the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/Drug Intermediates and Active Pharmaceuticals Ingredients (APIs) in the Country |
|
|
202 |
List of approved applicants under PLI Scheme for Medical Devices |
|
|
203 |
Press Notes regarding Approvals accorded under PLI Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the country. Dated: 9th December, 2021 |
|
|
204 |
Press Notes regarding Approval accorded under PLI Scheme for Promotion of Domestic Manufacturing of Medical Devices. Dated: 9th December, 2021 |
|
|
205 |
List of Approved Applicants under Production Linked Incentive (PLI) Scheme for Pharmaceuticals |
|
|
206 |
List of Approved Applicants under the the Production Linked Incentive (PLI) scheme for promotion of domestic manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates (DIs)/ Active Pharmaceutical Ingredients (APIs) in India |
|
|
207 |
Inviting details of local manufacturers of specific medical devices/equipments |
|
|
208 |
Corrigendum- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof -regarding. |
|
|
209 |
Press Release regarding Selection of applicants under the Production Linked Incentive (PLI) scheme for Pharmaceuticals |
|
|
210 |
Corrigendum- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof -regarding. |
|
|
211 |
FAQ: Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof |
|
|
212 |
Corrigendum- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof -regarding. |
|
|
213 |
Corrigendum- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof -regarding. |
|
|
214 |
Corrigendum: R.F.P. for Short Term Study and Long Term Study -Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof. |
|
|
215 |
Regarding- Draft Policy to Catalyze Research & Development and Innovation in the Pharma - MedTech Sector in India |
|
|
216 |
Circulation of Draft Policy to Catalyze Research & Development and Innovation in the Pharma- MedTech Sector in India |
|
|
217 |
R.F.P. for Long Term Study- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof. |
|
|
218 |
R.F.P. for Short Term Study- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof. |
|
|
219 |
Filling up the post of Managing Director, Bengal Chemicals & Pharmaceuticals Limited (BCPL) on deputation basis through Search-cum-Selection Committee (SCSC). |
|
|
220 |
Corrigendum under PLI scheme for Pharmaceuticals |
|
|
221 |
Filling up the post of Chief Executive Officer (CEO) in the Pharmaceutical and Medical Devices Bureau of India (PMBI), a Society under the aegis of Department of Pharmaceuticals, Government of India on deputation including short term contract. |
|
|
222 |
Invitation of Applications for Ofloxacin under the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in India. |
|
|
223 |
Notice for Time Extension of PLI for Bulk Drug and PLI for Medical Devices |
|
|
224 |
Notification regarding the revision of ceiling prices under para 18(i) of the Drugs (Prices Control) Order, 2013. |
|
|
225 |
Corrigendum- Operational Guidelines of PLI scheme for Pharmaceuticals |
|
|
226 |
Engagement of 04 Consultant(Non-tech, SO level) in the Department of Pharmaceuticals- reg |
|
|
227 |
Revised Notice- Invitation of Applications under the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the Country |
|
|
228 |
Corrigendum- Operational Guidelines of PLI scheme for Pharmaceuticals |
|
|
229 |
Annual Report 2020-21 |
|
|
230 |
Observing the 7th International Yoga Day, 2021. |
|
|
231 |
Revised Notice- Invitation of Applications Under the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the Country |
|
|
232 |
Revised Notice- Invitation of Applications Under the Production Linked Incentive (PLI) Scheme for Promoting Domestic Manufacturing of Medical Devices. |
|
|
233 |
Allocation of Tocilizumab Dated 11th May 2021 |
|
|
234 |
State-wise allocation of Remdesivir vials for period 21st April to 16th May, 2021 |
|
|
235 |
Revised allocation of Tocilizumab to States |
|
|
236 |
State-wise allocation of Remdesivir vials for period 21st April to 9th May, 2021 |
|
|
237 |
Order dated 25.03.2021 regarding items having sufficient local capacity and local competition as per Para 3(a) of revised Public Procurement (Preference to Make in India) Order dated 16.09.2020 |
|
|
238 |
Constitution of Internal Complain Committee to prevent Sexual Harassment of Women at workplace in respect of Ministry/Department and the attached/subordinate/ PSUs officers |
|
|
239 |
Hiring of 03 Consultants(Non-technical, Grade-II) and 04 Young Professionals as Consultants in Department of Pharmaceuticals on contract basis |
|
|
240 |
Action Plan of Swachhata Pakhwada from 1-15 September, 2021 |
|
|
241 |
List of winners of 6th India Pharma and India Medical Device Awards |
|
|
242 |
Detailed Demand for Grants (DDG), Demand No. 7 for the year 2021-22 |
|
|
243 |
Order dated 16.02.2021 regarding items having sufficient local capacity and local competition as per Para 3(a) of revised Public Procurement (Preference to Make in India) Order dated 16.09.2020 |
|
|
244 |
Revised Guidelines dated 16.02.2021 for implementing the provisions of revised Public Procurement (Preference to Make in India) Order dated 16.09.2020, related to procurement of Goods and Services in Medical Devices |
|
|
245 |
Notice Inviting for Tender -AMC Contract for NPPA Websites |
|
|
246 |
Request for Proposals (RFP) document on Selection of Public Financial Institution (Government Company) for providing services of Project Management Agency (PMA) for the implementation of Production Linked Incentive scheme for Pharmaceuticals. |
|
|
247 |
Projection of procurement for the next 05 years i.e 2021-22 to 2025-26 |
|
|
248 |
Advertisement for Selection of the post of Director(Finance), Bengal Chemicals & Pharmaceuticals Ltd. (BCPL), a schedule- C CPSE |
|
|
249 |
Corrigendum related to Selection of PMC through RFP under API-CF scheme |
|
|
250 |
Amended RFP document for Selection of PMC through RFP under API-CF scheme |
|
औषध विभाग
Department of
